Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

Go back to Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
(NASDAQ: TSHA) Delayed: 6.63 +0.21 (3.27%)
Previous Close $6.42    52 Week High
Open $6.50    52 Week Low
Day High $6.70    P/E N/A 
Day Low $6.47    EPS
Volume 1,484,710